chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial case was received from a consumer on 04 February 2013. The case represents a cluster of three unidentified patients, same vaccine, same lot number, same adverse event and same reporter. However, lot number does not correspond to product reported. The case is invalid, due to no patient identifiers were reported. Three unidentified patients, (age, birth date and gender not reported) received an injection reported as INFLUENZA VACCINE, Sanofi Pasteur Inc. lot number reported as C4347AA (which corresponds to product ADACEL), (route, site, side, and dose in series not reported) on unspecified days since January 2013. On unspecified dates, the patients developed cellulitis at site of injection. Past medical history, laboratory or diagnostic testing, and treatments were not reported. According to report, none of the patients were hospitalized. The patients' outcomes were not reported. Follow-up information was received from a healthcare professional on 05 February 2013. At least three patients received ADACEL (previously reported as Influenza Vaccine and developed cellulitis. The office said the ADACEL vaccine was warmer than usual upon delivery. Outcome was not reported. Documents held by sender: None.
Patient's arm where the shot was given started turning red and there is a huge bump.  The bump and redness is spreading over her left arm.  We believe it is from the Meningococcal Vaccine.
Hives, headache, muscle pain. 5 days later, Face and neck swelling. Followed by shortness of breath and muscle weakness. Continuing still 21 months later.
Student experienced an episode of syncope after administration of ADACEL and MENACTRA vaccines. Had student lay down with feet elevated. Observed. A & O x 3. VARIVAX then given. Released to school nurse for further observation. Time course: 11:15-11:30.
Patient called to report full body achiness, feeling flushed/feverish and shortness of breath on 9/26. Patient said onset of symptoms was a few hours after receiving the High Dose flu shot. She states that she has had the flu vaccines in past years, with no adverse issues, but this time she feels ill with symptoms listed about for about 5 days now.
Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included Heart disease, unspecified (Heart problems).    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain). At the time of the report, PAIN IN EXTREMITY (Arm pain) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication was reported by reporter. No treatment medication was reported by reporter.   This case was linked to MOD-2022-507293, MOD-2022-507166, MOD-2022-507720, MOD-2022-507719, MOD-2022-507713 (Patient Link).
Bright red rash on face, arms and buttocks.  Multiple urticarial lesions
pt recvd vax; exp chills, shakes, fever of 102;v; shot was given at 1:15pm; sxs started 6pm; given extra strenght apap;
Rigors, chills, almost unable to drive her car. Improved a little with Tylenol and cold medicine. Then 24 hrs after the vaccine, developed red, warm, painful arm where shot was administered which spread around under deltoid, pain radiated to hand. Improved a little 2 d later on Bactrim DS.
I woke up hoarse, I went to doctor next day. I was on voice rest and I kept waking up the days feeling like I had strep, then congestion like a sinus infection and headaches. I quarantined for more then ten days. The day I got my test results, January 1st I went and received monoclonal antibodies at the ER, which was 6 days after my symptoms started.
This spontaneous report as received from a certified medical assistant (C.M.A.) refers to an unspecified number of patients of unknown age and gender. Current conditions, medical history and concomitant therapies were not reported. In approximately 2015 (reported as on unspecified dates since 18-AUG-2015), the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 injection (lot# K007262 with expiration date 19-MAR-2016 and lot# K007262 with expiration date 24-NOV-2015, dose and route of administration were not reported). No adverse reactions were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Patient got the Pfizer covid vaccine, and he experienced a sore arm.; This is a spontaneous report from a contactable consumer reported for a male patient (Reporters wifes father) that: Report 5 of 5. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot number: unknown), via an unspecified route of administration on an unspecified date in 2021 as single dose for COVID-19 immunization.  Medical history and concomitant medications were not reported.  The patient got the Pfizer COVID vaccine, and he experienced a sore arm on an unspecified date in 2021.  The outcome of the event was unknown.    Information on batch/lot number has been requested.
After second dose total body aches, shaking chills, headache and fever lasted x 24 hours. Filed v safe as requested. 5 months after second dose had abnormal mammogram and needed surgery to remove mass, Atypical Ductal Hyperplasia was pathology report. When preparing for surgery had abnormal EKG showing R BBB and left axis deviation, possible anterior MI, subsequent Stress and Echo showed mild left ventricular enlargement and pulmonary artery concern. V Safe advised me to file VAER report, I waited until results of testing available
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021 at 2:08 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 2:08 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 31.79. Concomitant products were not provided. On 27-Mar-2021, Excursion time was 09 AM and 10 AM, temperature was 35, total doses given for the day was 195, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 27-Mar-2021. 20 vials were sent to clinic. Vaccine BUD date was 22-Apr-2021. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F. Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
Woke up shivering with chills and headache, added blankets and took Tylenol then got too hot. Temperature in morning 99.6. Continuing headaches, congestion, feeling hot and cold at the same time,  aches and pains and fatigue.
came back w/urticaria, fever p/vax this morning w/DTP/OPV/HIB/HEP B @ the rt deltoid area;pt injected w/Epi & instructed to take DPH elixir;
Pt had HPV #2 on 7/7/2020. Started fever and pain on (L) knee on 7/8/2020. Fever resolved on 7/9/2020 but started to have pain on (L) knee and both feet. Symptoms persisted for 2 weeks with swelling on (R) hand and (R) foot. No cough, runny nose or fever noted. Seen in clinic on 7/24 for school PE. Child referred to hospital for admission 7/24/20
Developed a tic - one day after getting flu vaccine. Mom describes as constant clearing of her throat. Currently observing at home. (Phone report) also happened last year.
She felt awful,legs felt warm,chills,leg pain.The next day after the vaccination.She vomited once. She then felt slightly better until 9/04/2020 when she had a headache,nausea and fatigue.Found to have an extremely elevated WBC. Sent to ED for admission .Admitted to the PICU on 9/11/2020 ,Diagnosed with T cell ALL .Currently in the hospital.
Pt received inj 9/20/16 within a hour had a rash on arms, legs and neck - had OV on 9/21/16 - Dr. prescribed MEDROL Dose pak and 1.0 ml inj of DEPO-MEDROL, 9/26/16 OV - rash spreading, gave prednisone 5 mg 3 tabs once daily, OV - 10/3/16 still had rash - 10/20/16 OV - rash improving.
The mother was 38 Weeks pregnant at the onset of the event; Chills, aching at injection site, and low grade fever; Chills, aching at injection site, and low grade fever; Chills, aching at injection site, and low grade fever/Highest recorded fever 99.7 degrees F; This is a spontaneous report from a contactable other HCP.  A 34-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration from 02Feb2021 14:30 at SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported.  Concomitant medication included minerals nos, vitamins nos (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]). The patient received first dose of BNT162B2 for COVID-19 vaccine on 12Jan2021 at 2:30pm in left arm. The patient's second dose was on 02Feb2021 and the patient was approximately 37 weeks pregnant. That night and the next day, on 04Feb2021 12:45, the patient had chills, aching at injection site, and low grade fever for which the patient took acetaminophen prn (as needed). Highest recorded fever 99.7 degrees F. The mother was 38 Weeks pregnant at the onset of the event. On Feb2021 at 12:50am, the patient's water broke 2.5 weeks before the due date. The patient was admitted to the local hospital and the baby was delivered without complications. Discharged on 05Feb2021. Unsure if early delivery related to vaccination, but thought it worth reporting since there is limited data on pregnant women and the vaccine. The patient underwent lab tests and procedures which included body temperature: low grade fever fahrenheit, body temperature: 99.7 fahrenheit on Highest recorded fever 99.7 degrees F, sars-cov-2 test: negative on 03Feb2021. Treatment was received for the event low grade fever. The outcome of the events was unknown.  Information about lot/batch number has been requested.
GI - nausea/vomiting, tachycardia, and injection site rash within 30 min of injection
Information has been received from a physician concerning her daughter who on an unspecified date was vaccinated with a dose of Gardasil (lot 654510/0926F). Immediately after receiving Gardasil, her daughter experienced severe pain in area of injection site. There was no visible reaction at the injection site such as a rash or swelling. At the time of this report, the outcome was unknown. This is one of several reports from the same source. Additional information has been requested. This is in follow-up to reports previously submitted on 5/14/2007. Information has been received from a physician concerning her daughter who on an unspecified date was vaccinated with a dose of Gardasil (lot 654510/0926F). Immediately after receiving Gardasil, her daughter experienced severe pain in area of injection site. She complained of a burning sensation after the injection. The physician stated that Hepatitis and B12 shots did not hurt as bad as GARDASIL. The physician reported that the pain lasted 24-28 hours and described it to the feeling of receiving an IV of potassium. There was no visible reaction at the injection site such as a rash or swelling. At the time of this report, the outcome was unknown. This is one of several reports from the same source. Additional information has been requested.
21 hours after vaccination: bruise, chills, fatigue, soreness at injection site, slight swelling at injection site.   56 hours after vaccination:  bruise now larger,  redness  still prevalent, itchiness has started near injection site.  Chilles and fatigue are gone.
Mold/moderate wheeze and chest tightness.  Onset ~20 min after administration.  Lasted 30-45 minutes.
Pt recv vax on 7/29/98; on 7/31/98 pt exp swelling at injection site.
a wave a mild nausea; bad headache; muscle aches in my back and body; soreness; stomach pain; fatigue; This is a spontaneous report from a contactable pharmacist (patient). A 48-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, lot number: EC8982, expiration date was not reported), via intramuscular, administered in left arm on 01Feb2021 08:00 (at the age of 48-years-old) as dose 2, single for covid-19 immunization at hospital. The patient medical history was not reported. Concomitant medications included methylphenidate, vitamin d [vitamin d nos], calcium carbonate, ibuprofen, all taken for unknown indications from an unknown date. Other medications the patient received within 2 weeks of vaccination included methylphenidate, Vitamin D, Calcium carbonate, ibuprofen. The patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: solution for injection, lot number: EH9899, expiration date was not reported), via intramuscular, administered in left arm on 07Jan2021 02:45 PM (at the age of 48-years-old) as dose 1, single for covid-19 immunization. Patient was not pregnant at the time of vaccination. The patient does not have any Allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  The start date and time for events was reported as 08Feb2021 04:00PM. It was reported that, initially after the 2nd injection 01Feb2021, after the first 10 minutes she felt a wave a mild nausea that was gone within 2 hours. The next day at 5am she woke up with a bad headache for which she took 800mg ibuprofen. It got some better, but by the time the med wore off in 6-8h it was bad again and took another dose. The HA was gone by that night. However, 7 days later around 4pm 08Feb, she felt muscle aches in my back and body, like soreness, HA returned, she had stomach pain and mild nausea and good amount of fatigue. she didn't feel like prepping the dinner she bought, so her husband handled that and bedtime for kids. she took 800mg ibuprofen again. By 10pm, she felt some better, but woke up the next am 09Feb still fatigued & with HA. She went back to bed for an hour after getting kids off to school. After that she felt fine until about 4pm again when she felt stomach pain again, high up, soreness in back & fatigue. Lasted 3-4h. Today, 10Feb, she still have dull bothersome HA across my forehead and fatigue. Ibuprofen 800mg was received as treatment for adverse event. Therapeutic measures were taken for all events. The reporter assessed the seriousness as non-serious. The outcome of the events was reported as not recovered.  Follow-up attempts are completed. No further information is expected.
first dose two years ago; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose, two years ago from the day of reporting).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The case was self-reported. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix as per the vaccination schedule, which led to incomplete course of vaccination. The patient asked if he/she could take the 2nd dose now. The follow-up would not possible as no contact details were available.
Pt recvd 3 doses of Engerix-B on 19APR90, 1JUN90, & 13NOV90 & 14AUG91 it was determined by titer result that pt did not respond to vax series;
Patient complained of redness, itching, and warmth at injection site starting day after injection. Symptoms abating as day progressed. Continued lessening today, 10-26-2020..
family placed pt in hospice due to altered mental state and new onset of aphasia; acute encephalopathy; not eating or drinking; hospice doctor and doctor that signed the death certificate listed COVID with long term complications as a comorbidity and condition leading to death; pt died in the hospice facility
Shingles; Redness all around breasts and back; Pain all around the redness; Pain all around the redness; Small red bumps; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), ERYTHEMA (Redness all around breasts and back), BACK PAIN (Pain all around the redness), BREAST PAIN (Pain all around the redness) and SKIN LESION (Small red bumps) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced SKIN LESION (Small red bumps). On 13-May-2021, the patient experienced ERYTHEMA (Redness all around breasts and back), BACK PAIN (Pain all around the redness) and BREAST PAIN (Pain all around the redness). On 14-May-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles), ERYTHEMA (Redness all around breasts and back), BACK PAIN (Pain all around the redness), BREAST PAIN (Pain all around the redness) and SKIN LESION (Small red bumps) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Patient sent pictures to her doctor, who confirmed that the bumps are shingles. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow up correspondence received on 13 Jul 2021 and does not contain new information.
extra dose given accidently along with other vaccines. monitoring for reaction. along with MMR, Var, Hib, and PCV13
Moderna Arm (delayed sight reaction) swelling and hot to touch with a definitive redness and oval in shape. Has grown 3 x larger over night. Some itching and pain. No medicine taken and not too uncomfortable. On day two of the reaction.
Mother states at approximately 4:30pm on 8/27/21, patient had seizure lasting 45 seconds involving eye rolling, full body movements, and diaphoresis. Five minutes later, she appeared to have another seizure lasting 90 seconds involving eye rolling, upper body movements, and diaphoresis. Temperature not taken, mother states pt. did not feel warm. Following seizure, no further symptoms. Mother states this was first seizure like activity noted in patients medical history and patient suffers no residual effects. Mother denies seeking medical care at time of seizure and monitored patient at home. Mother states pt. medically stable for the last 72 hours. Report was made to Pediatric Office on 8/31/21 @ approximately 9:30AM.
Expired Product Used; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number 477Z7, expiry date 7th December 2021) for prophylaxis.   On 11th March 2022, the patient received the 2nd dose of Shingrix. On 11th March 2022, unknown after receiving Shingrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The case was reported by Medical Assistant. The reporter stated that, the patient was administered expired dose of Shingrix, which led to expired vaccine used. At the time of reporting, a repeat dose had not been administered. The vaccine administration facility was the same as Primary reporter. The reporter consented to follow up.
No additional AE; ROTATEQ that underwent a temperature excursion was administered; This spontaneous report was received from a physician referring to a patient of unknow age and gender patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 15-JUN-2021, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number 1688504 and expiration date of 19-NOV-2021 for prophylaxis (dose was not reported).   The administered dose of the vaccine experienced a temperature excursion of 2°C to 8°C (9.5°C) for 0 hours 40 minutes 0 seconds, as recorded by a data logger.   There was no previous temperature excursion. No additional adverse events were reported.
On 03/20/2003 pt c/o left arm swollen from elbow to shoulder with fever and chills. Pt took Benadryl and symptoms went away. Stayed swollen for several days.
Pt walked up to us stating that she feels itchy in her arms, chest and legs.  Pt also reported her fingers feeling "fat".  Pt has a history of allergic reactions and was at minute 17 of her 30 min wait.   Pt presented with her chief complaint along with redness on her arms and chest. Symptoms persisted for 10 minutes and resolved on their own. Pt never had sob, swelling of lips/tongue.
Patient felt faint and clamminess after vaccination.  Instructed patient to sit down and rest for awhile.  After about 15 minutes patient felt much better.
Patient over 1 week later is still experiencing hives all over body including face, itching, swelling of some areas.
Pain at injection site and swelling and discomfort in opposite arm where I received my Influenza injection 6 weeks before.
Urticarial rash on Left anterior thigh-started in 12-15 hours after DTaP was given in that thigh.  No fever, no resp sx reactivity Txd with Benadryl PO